WWM
BTCY

Wolff Wiese Magana’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Wolff Wiese Magana’s Portfolio BTCY Stock Details BTCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-167
Closed -$2K – 997
2022
Q1 		$2K Hold
167
– – ﹤0.01% 742
2021
Q4 		$4K Hold
167
– – ﹤0.01% 674
2021
Q3 		$3K Buy
+167
New +$3.13K ﹤0.01% 695

Other funds holding BTCY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
SWMP
Signature Wealth Management Partners Montvale, New Jersey $214M AUM 27.04% 1-Year Est. Return
PWM
PRW Wealth Management Quincy, Massachusetts $262M AUM 22.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wolff Wiese Magana's BTCY Position: Q2 2022 in Review

Wolff Wiese Magana sold out of Biotricity, Inc. Common Stock (BTCY) in Q2 2022, closing a stake of 167 shares — an estimated $2K sold.

Wolff Wiese Magana first reported a position in BTCY in Q3 2021 and held it in 3 quarters. The position peaked at $4K in Q4 2021. 27 funds tracked by Wall St. Rank hold BTCY as of Q2 2022.

  • Wolff Wiese Magana reported no remaining Biotricity, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Wolff Wiese Magana sold 167 Biotricity, Inc. Common Stock shares in Q2 2022, an estimated $2K.
  • Wolff Wiese Magana first reported a position in Biotricity, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • Wolff Wiese Magana's Biotricity, Inc. Common Stock position peaked at $4K in Q4 2021.
  • 27 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q2 2022.

Based on Wolff Wiese Magana's 13F filing for Q2 2022, filed 15 Jul 2022.